Results 31 to 40 of about 104,265 (300)
, 2023 Chemotherapy-induced side effects restrain anti-tumor efficiency, with hyperlipidemia being the most common accompanying disease to cause treatment failure.
Hua Cai +11 more
core +1 more source
Fucoidans in Nanomedicine [PDF]
Marine Drugs, 2016 Fucoidans are widespread cost-effective sulfated marine polysaccharides which have raised interest in the scientific community over last decades for their wide spectrum of bioactivities. Unsurprisingly, nanomedicine has grasped these compounds to develop innovative therapeutic and diagnostic nanosystems. The applications of fucoidans in nanomedicine as
Chollet, Lucas +5 more
openaire +5 more sources
Preparation techniques, functionalization, and cytotoxicity of magnetic nanoparticles: A review
Journal of Contemporary Pharmacy, 2022 In the relatively new but fast-evolving field of nanomedicine and nanotransport systems, different nanoscale molecules are used to deliver therapeutic agents to precisely targeted sites or potentially function as diagnostic tools.
Humaira Sultana +4 more
doaj +1 more source
The consolidation of nanomedicine [PDF]
WIREs Nanomedicine and Nanobiotechnology, 2019 AbstractOver the past two decades, nanomedicine has grown steadily, however, without inducing a palpable shift in the diagnosis and treatment of diseases so far. While this may simply be a consequence of the slow, incremental nature that characterizes many modern technologies, this article posits that there is another set of significant factors ...
Raphael Zingg, Marius Fischer
openaire +3 more sources
Drug Delivery, 2018 Epithelial to mesenchymal transition (EMT) has emerged as a key process in the development of renal fibrosis. In fact, EMT-derived fibroblasts contribute to the progression of chronic renal disease.
Anna Sola +8 more
doaj +1 more source
Nanomedicine: A systems engineering approach
, 2009 This book offers a fundamental and comprehensive overview of nanomedicine from a systems engineering perspective, making it the first book in the field of quantitative nanomedicine based on systems theory.
Zhang, Mingjun, Xi, Ning
core +1 more source
Nature Reviews Cancer, 2022 The field of cancer nanomedicine seeks to overcome the inherent shortcomings of conventional cancer diagnostics and therapies. Yet despite the surge of interest in and attractive attributes of nanotechnologies, challenges remain in their clinical translation, prompting some to argue that they have not yet reached their true potential. In this Viewpoint
Sangeeta N. Bhatia +3 more
openaire +2 more sources
The success of nanomedicine [PDF]
Nano Today, 2020 In recent years, the promise and prospects of nanomedicine have been controversially discussed. We here argue that nanomedicine has undeniably been successful, not only academically and preclinically, but also industrially and clinically. To ensure that we keep on making progress, we have to move away from over-focusing on nano and on materials ...
Lammers, Twan, Ferrari, Mauro
openaire +2 more sources
Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases
, 2023 Retinal diseases are one of the leading causes of blindness globally. The mainstay treatments for these blinding diseases are laser photocoagulation, vitrectomy, and repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) or ...
Binapani Mahaling +8 more
core +1 more source
The Nanomedicines Alliance: An Industry Perspective on Nanomedicines
Journal of Nanomedicine & Nanotechnology, 2014 The field of nanomedicines has expanded significantly in recent years in the breadth of compounds under development as well as in the types of technology that are being applied to generate nanomedicines. The pathway to licensure of new nanomedicines is sufficiently well defined by existing regulations and guidance.
openaire +2 more sources